HHL-B:CA:TSX-Harvest Healthcare Leaders Income ETF (CAD)

ETF | Others |

Last Closing

CAD 9.125

Change

-0.10 (-1.08)%

Market Cap

N/A

Volume

702.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-02 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

N/A

CAD 6.19B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

+0.01 (+0.02%)

CAD 4.83B
PHYS-U:CA Sprott Physical Gold Trust

+0.02 (+0.11%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

N/A

CAD 4.54B
HXT-U:CA Horizons S&P/TSX 60 Index ETF

+1.03 (+2.52%)

CAD 3.92B
XEQT:CA iShares Core Equity Portfolio

+0.06 (+0.19%)

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

N/A

CAD 3.78B
PSLV-U:CA Sprott Physical Silver Trust

+0.25 (+2.49%)

CAD 3.29B
NSCB:CA NBI Sustainable Canadian Bond ..

-0.12 (-0.55%)

CAD 2.78B
NUBF:CA NBI Unconstrained Fixed Income..

+0.12 (+0.58%)

CAD 2.52B

ETFs Containing HHL-B:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.85% 60% D- 57% F
Dividend Return 0.68% 53% F 25% F
Total Return 7.53% 61% D- 56% F
Trailing 12 Months  
Capital Gain 8.12% 52% F 55% F
Dividend Return 1.38% 69% C- 32% F
Total Return 9.49% 53% F 51% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 2.03% 58% F 49% F
Dividend Return 2.12% 58% F 43% F
Total Return 0.09% 61% D- 16% F
Risk Return Profile  
Volatility (Standard Deviation) 4.29% 78% C+ 91% A-
Risk Adjusted Return 49.27% 79% B- 72% C
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:

There is nothing we particularly dislike